Why we need continuous pharmaceutical manufacturing and how to make it happen: a summary of thoughts from the international symposium on continuous manufacturing

Clive Badman, Charles L. Cooney, Robert T. Haslam, Alastair Florence, Konstantin Konstantinov, Markus Krumme, Salvatore Mascia, Moheb Nasr, Bernhardt L. Trout, Raymond F. Baddour

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time.

Original languageEnglish
Pages (from-to)3521-3523
Number of pages3
JournalJournal of Pharmaceutical Sciences
Volume108
Issue number11
Early online date2 Aug 2019
DOIs
Publication statusPublished - 30 Nov 2019

Keywords

  • continuous manufacturing
  • pharmaceutical manufacturing
  • pharmaceutical technology

Fingerprint Dive into the research topics of 'Why we need continuous pharmaceutical manufacturing and how to make it happen: a summary of thoughts from the international symposium on continuous manufacturing'. Together they form a unique fingerprint.

  • Cite this